The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk prediction model for taxane-induced peripheral neuropathy (TIPN) in patients with early-stage cancer receiving taxane therapy: SWOG S1714.
 
Meghna S. Trivedi
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Phoenix Molecular Designs (Inst); Regeneron (Inst)
 
Joseph M. Unger
Consulting or Advisory Role - AstraZeneca
 
Norah Lynn Henry
Consulting or Advisory Role - AstraZeneca; Myovant Sciences
Research Funding - Blue Note Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Royalty from Up-to-Date
 
Amy Darke
No Relationships to Disclose
 
Daniel Louis Hertz
Other Relationship - Advocates for Universal DPD/DPYD Testing (AUDT)
(OPTIONAL) Uncompensated Relationships - Saladax Biomedical
 
Thomas Brannagan
Honoraria - Alexion Pharmaceuticals; Alnylam; AstraZeneca; CSL Behring; Immunovant; Ionis Pharmaceuticals; Sangamo Bioscience
Speakers' Bureau - Akcea Therapeutics; CSL Behring; Grifols
Research Funding - Alnylam (Inst); Argenx (Inst); Argenx (Inst); Catalyst Pharmaceuticals (Inst); Grifols (Inst); Ionis Pharmaceuticals (Inst); Pharnext (Inst)
 
Stephanie Smith
No Relationships to Disclose
 
Bryan P. Schneider
Research Funding - Foundation Medicine; Genentech/Roche; Pfizer
 
William Johnson Irvin
Research Funding - Altor BioScience (Inst); Altor BioScience (Inst); AstraZeneca (Inst); Boston Biomedical (Inst); Genentech (Inst); Merck (Inst); Novartis (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tempus (Inst)
 
Amanda Redden Hathaway
Consulting or Advisory Role - Gilead Sciences; Lilly
Speakers' Bureau - Lilly
 
Amy C. Vander Woude
Employment - Cancer & Hematology Centers of Western Michigan; Plastic Surgery Associates (I)
Leadership - Cancer & Hematology Centers of Western Michigan
Stock and Other Ownership Interests - OneOncology
Travel, Accommodations, Expenses - OneOncology
 
Vinay K. Gudena
Stock and Other Ownership Interests - Lilly; Merck
Honoraria - Daiichi Sankyo/Lilly
Consulting or Advisory Role - Cardinal Health; Daiichi Sankyo/Lilly; Genomic Health; Pfizer; Pfizer
 
Paula Anel Cabrera-Galeana
Speakers' Bureau - AstraZeneca/Merck; Novartis; Pfizer/Lilly
 
Mary Orsted
Employment - HealthPartners
 
Michael Leo LeBlanc
Consulting or Advisory Role - Agios
 
Michael Jordan Fisch
Employment - Carelon Medical Benefits Management
Stock and Other Ownership Interests - Anthem
 
Dawn L. Hershman
Consulting or Advisory Role - AIM Specialty Health